Form D Worth Mentioning: Tesorx Pharma $5.00 million Fundraising. Ramachandran Thirucote Filed Jul 13 SEC Filing

Pharmaceuticals Tesorx Pharma, Llc - Ramachandran Thirucote

Tesorx Pharma Financing

Tesorx Pharma, Llc, Limited Liability Company just filed form D because of $5.00 million equity financing. This is a new filing. Tesorx Pharma was able to sell $697,532 so far. That is 13.95% of the fundraising. The total fundraising amount was $5.00 million. The fundraising form was filed on 2016-07-13. The reason for the financing was: unspecified. The fundraising still has about $4.30 million more and is not closed yet. We have to wait more to see if the offering will be fully taken.

Tesorx Pharma is based in California. The firm’s business is Pharmaceuticals. The D form was submitted by Ramachandran Thirucote Chief Executive Officer. The company was incorporated more than five years ago. The filler’s address is: 325 Sharon Park Drive, Suite 739, Menlo Park, Ca, California, 94025-6805. Ramachandran Thirucote is the related person in the form and it has address: C/O Tesorx Pharma, Llc, 325 Sharon Park Drive, Suite 739, Menlo Park, Ca, California, 94025-6805. Link to Tesorx Pharma Filing: 000155425816000002.

Analysis of Tesorx Pharma Offering

On average, startups in the Pharmaceuticals sector, sell 60.90% of the total offering size. Tesorx Pharma sold 13.95% of the offering. The financing is still open. The average financing size for companies in the Pharmaceuticals industry is $556,000. The total amount raised is 25.46% bigger than the average for companies in the Pharmaceuticals sector. The minimum investment for this financing was set at $0. If you know more about the reasons for the fundraising, please comment below.

What is Form D? What It Is Used For

Form D disclosures could be used to track and understand better your competitors. The information in Form D is usually highly confidential for ventures and startups and they don’t like revealing it. This is because it reveals amount raised or planned to be raised as well as reasons for the financing. This could help competitors. Entrepreneurs usually want to keep their financing a ‘secret’ so they can stay in stealth mode for longer.

Why Fundraising Reporting Is Good For Tesorx Pharma Also

The Form D signed by Ramachandran Thirucote might help Tesorx Pharma, Llc’s sector. First, it helps potential customers feel more safe to deal with a firm that is well financed. The odds are higher that it will stay in the business. Second, this could attract other investors such as venture-capital firms, funds and angels. Third, positive PR effects could even bring leasing firms and venture lenders.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related posts

Leave a Comment